SCHEMBL2370973

SCHEMBL2370973

CCOC(=O)C(C)(Cc1ccc(N)cc1)C(=O)OCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.59
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
LMNA P02545 3/20 0.51
MAOA P21397 1/20 0.51
PPID Q08752 3/20 0.50
PPIB P23284 1/20 0.50
PPIA P62937 1/20 0.50
PPIG Q13427 1/20 0.50
ALDH1A1 P00352 3/20 0.44
RECQL P46063 1/20 0.44
PPARG P37231 1/20 0.42
TSHR P16473 2/20 0.41
ABCB11 O95342 1/20 0.41
HTR2A P28223 1/20 0.41
PMP22 Q01453 1/20 0.41
PPARA Q07869 1/20 0.41
OPRK1 P41145 1/20 0.40
FDPS P14324 1/20 0.40
PRKCZ Q05513 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28737716 0.88 MMP8 (0.60) MMP8CYP1A2CYP3A4LMNAALDH1A1
SCHEMBL7362869 0.86 MMP8 (0.59) MMP8CYP1A2CYP3A4LMNAALDH1A1
SCHEMBL458395 0.85 MMP8 (0.57) MMP8CYP1A2CYP3A4LMNAMAOA
SCHEMBL28753087 0.85 MMP8 (0.57) MMP8CYP1A2LMNAALDH1A1RECQL
SCHEMBL8710582 0.84 MMP8 (0.79) MMP8LMNAPPIDALDH1A1RECQL
SCHEMBL24733330 0.83 MMP8 (0.56) MMP8CYP1A2CYP3A4LMNAALDH1A1
SCHEMBL15905970 0.83 MMP8 (0.56) MMP8CYP1A2CYP3A4LMNAMAOA
SCHEMBL7380944 0.82 MMP8 (0.55) MMP8CYP1A2CYP3A4LMNAALDH1A1
SCHEMBL12142745 0.82 MMP8 (0.55) MMP8CYP1A2CYP3A4LMNAMAOA
SCHEMBL3629075 0.81 LMNA (0.50) MMP8CYP1A2CYP3A4LMNAMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150272947-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2015-10-01 US disclosed
US-9067888-B2 Inhibitors of protein kinases ASTRAZENECA AB (SE) 2015-06-30 US disclosed
US-20130345233-A1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2013-12-26 US disclosed
US-8518948-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-08-27 US disclosed
EP-2545037-A1 INHIBITORS OF PROTEIN KINASES Ingenium Pharmaceuticals GmbH (DE) 2013-01-16 EP disclosed
US-20110224225-A1 Inhibitors of protein kinases ASTRAZENECA AB (SE) 2011-09-15 US disclosed
WO-2011110612-A1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2011-09-15 WO disclosed
US-5208240-A Alzeheimer's, cardiovascular, respiratory MERRELL DOW PHARMACEUTICALS INC. (US) 1993-05-04 US disclosed
EP-0503563-A2 Novel 8-substituted purines as selective adenosine receptor agents MERRELL PHARMACEUTICALS INC. (US) 1992-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130345233-A1 INHIBITORS OF PROTEIN KINASES CDK1, CDK2, CDK3 MMP8 3678/4885CYP1A2 2200/4885CYP3A4 3737/4885
US-20150272947-A1 INHIBITORS OF PROTEIN KINASES CDK1, CDK2, CDK3 MMP8 3678/4885CYP1A2 2200/4885CYP3A4 3737/4885
US-20110224225-A1 Inhibitors of protein kinases CDK1, CDK2, CDK3 MMP8 3678/4885CYP1A2 2200/4885CYP3A4 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.